PubRank

Angelo Viscido

Author PubWeight™ 14.15‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Another paradox in Crohn's disease: new onset of psoriasis in a patient receiving tumor necrosis factor-alpha antagonist. Inflamm Bowel Dis 2007 1.46
2 MR imaging in patients with Crohn disease: value of T2- versus T1-weighted gadolinium-enhanced MR sequences with use of an oral superparamagnetic contrast agent. Radiology 2005 1.23
3 Cytomegalovirus infection in inflammatory bowel disease patients undergoing anti-TNFalpha therapy. J Clin Virol 2008 1.13
4 Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 2002 1.12
5 Small intestine contrast ultrasonography: an alternative to radiology in the assessment of small bowel disease. Inflamm Bowel Dis 2005 1.03
6 A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis 2005 1.03
7 Anti-tissue transglutaminase antibodies in inflammatory bowel disease: new evidence. Clin Chem Lab Med 2004 1.02
8 Current management of severe ulcerative colitis. Nat Clin Pract Gastroenterol Hepatol 2007 0.84
9 Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis 2006 0.83
10 Safe use of infliximab for the treatment of fistulizing Crohn's disease during pregnancy within 3 months of conception. Inflamm Bowel Dis 2008 0.82
11 GI distension in severe ulcerative colitis. Am J Gastroenterol 2002 0.81
12 Non-Celiac Gluten Sensitivity among Patients Perceiving Gluten-Related Symptoms. Digestion 2015 0.80
13 Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis. World J Gastroenterol 2011 0.77
14 Development of fistulae in ileo-anal pouch does not necessarily indicate Crohn's disease. Am J Gastroenterol 2004 0.75
15 Successful treatment with infliximab of refractory pyoderma gangrenosum in 2 patients with inflammatory bowel diseases. Inflamm Bowel Dis 2007 0.75
16 The Role on Endoscopy in Alcohol-Related Diseases. Rev Recent Clin Trials 2016 0.75